Small molecule XIAP inhibitors have been shown to synergize with TRAIL to induce apoptosis and inhibit the long-term clonogenic survival of pancreatic carcinoma cells [21]. The gene discussed is XIAP; the disease is exocrine pancreatic carcinoma.